Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-05-24 37963
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-28 2022-03-24 153783
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-31 2018-05-05 37732
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-27 2023-01-06 175895
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-24 2020-08-17 118766
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-04 2022-12-23 173831
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-07-25 2018-10-25 56541
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137261
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137264
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-09 2022-01-06 148999
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-29 2022-01-29 150181
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-25 2021-07-22 139848
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-13 2018-07-03 39659
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 1MG TABLET Discontinued 2017-03-30 2018-02-05 4745
APO-TICAGRELOR 60MG TABLET Discontinued 2025-11-19 2025-11-20 257747
APO-TICAGRELOR 60MG TABLET To be discontinued 2025-11-12 2025-11-20 257700
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-TIMOP OPH SOLN 0.25% Discontinued 2019-01-02 2019-01-02 70818
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-TOLTERODINE 1MG TABLET Discontinued 2018-09-08 2019-01-17 60822
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TRAZODONE TABLETS 100MG 100MG TABLET Discontinued 2018-09-08 2018-09-15 60831
APO-TRAZODONE TABLETS 50MG 50MG TABLET Discontinued 2018-09-08 2018-09-15 60834
APO-VALACYCLOVIR 500MG TABLET Discontinued 2018-09-08 2018-09-15 60840
APO-VALGANCICLOVIR 450MG TABLET Discontinued 2018-09-08 2018-09-15 60843
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054